Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 6, keine Gesamtzahl für „Lenvima“
Suchtreffer
Begriffe & Kennungen
Lenvima · 4.8 · Increased blood thyroid stimulating hormone (see section 4.4)
Eintrag öffnenLenvima · 4.8 · Lenvatinib use has been associated with cases of fistulae including reactions resulting in death. Reports of f
Eintrag öffnenLenvima · 4.8 · Non-gastrointestinal fistulae (see section 4.4)
Eintrag öffnenLenvima · 4.8 · Other special populations
Eintrag öffnenLenvima · 4.8 · Paediatric population
Eintrag öffnenLenvima · 4.8 · Patients of age ≥75 years were more likely to experience Grade 3 or 4 hypertension, proteinuria, decreased app
Eintrag öffnenLenvima · 4.8 · Patients of age ≥75 years were more likely to experience hypertension, proteinuria, decreased appetite, asthen
Eintrag öffnenLenvima · 4.8 · Patients of age ≥75 years were more likely to experience urinary tract infections and Grade ≥3 hypertension (≥
Eintrag öffnenLenvima · 4.8 · Patients with a baseline Child-Pugh (CP) score of 6 (about 20% patients in the REFLECT study) had a higher inc
Eintrag öffnenLenvima · 4.8 · Patients with baseline hepatic impairment had a higher incidence of hypertension and PPE, and a higher inciden
Eintrag öffnenLenvima · 4.8 · Patients with baseline hypertension had a higher incidence of Grade 3 or 4 hypertension, proteinuria, diarrhoe
Eintrag öffnenLenvima · 4.8 · Patients with baseline renal impairment had a higher incidence of Grade 3 or 4 hypertension, proteinuria, fati
Eintrag öffnenLenvima · 4.8 · Patients with baseline renal impairment had a higher incidence of fatigue, hypothyroidism, dehydration, diarrh
Eintrag öffnenLenvima · 4.8 · Patients with body weight <60 kg
Eintrag öffnenLenvima · 4.8 · Patients with low body weight (<60 kg) had a higher incidence of PPE, proteinuria, of Grade 3 or 4 hypocalcaem
Eintrag öffnenLenvima · 4.8 · Posterior reversible encephalopathy syndrome (PRES) / Reversible posterior leucoencephalopathy syndrome (RPLS)
Eintrag öffnenLenvima · 4.8 · Proteinuria (see section 4.4)
Eintrag öffnenLenvima · 4.8 · QT interval prolongation (see section 4.4)
Eintrag öffnenLenvima · 4.8 · Renal impairment
Eintrag öffnenLenvima · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnen